SCHEMBL14360940

SCHEMBL14360940

CCOC(=O)CC(=O)Nc1ccc2c(c1)c(Cl)nn2CC1CCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ GRM4 Q14833 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ ELANE P08246 5/20 0.38
▸ MAPT P10636 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ F2 P00734 2/20 0.37
▸ CTRB1 P17538 2/20 0.37
▸ PLAU P00749 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ P2RY14 Q15391 1/20 0.37
▸ CYSLTR2 Q9NS75 1/20 0.37
▸ CYSLTR1 Q9Y271 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14361085 0.96 TSHR (0.42) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL14360962 0.93 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL14361090 0.85 HPGD (0.45) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL5306381 0.84 CYP3A4 (0.45) ALDH1A1GAATSHRHPGDELANE
SCHEMBL27693955 0.81 OPRM1 (0.43) GRM4P2RY14
SCHEMBL14361036 0.81 L3MBTL1 (0.44) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL14360901 0.81 AR (0.45) KMT2AL3MBTL1GRM4MAPTP2RY14
SCHEMBL5436150 0.79 KDM4E (0.43) ALDH1A1MEN1KMT2AGAAGRM4
SCHEMBL5305001 0.77 MEN1 (0.48) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL14360912 0.77 TYK2 (0.47) HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070265325-A1 Nitro Indazole Derivatives ASTRAZENECA AB (SE) 2007-11-15 — — US disclosed
US-20070265325-A1 Nitro Indazole Derivatives ASTRAZENECA AB (SE) 2007-11-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265325-A1 Nitro Indazole Derivatives NOS3, CYP3A43, NOS2 ALDH1A1 490/4885MEN1 3405/4885KMT2A 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback